| 注册
首页|期刊导航|临床肝胆病杂志|加强基于大数据的药物性肝损伤的科学研究和监管

加强基于大数据的药物性肝损伤的科学研究和监管

茅益民

临床肝胆病杂志2018,Vol.34Issue(6):1166-1168,3.
临床肝胆病杂志2018,Vol.34Issue(6):1166-1168,3.DOI:10.3969/j.issn.1001-5256.2018.06.005

加强基于大数据的药物性肝损伤的科学研究和监管

Strengthening the scientific research and supervision of drug-induced liver injury based on big data

茅益民1

作者信息

  • 1. 上海交通大学医学院附属仁济医院,上海市消化疾病研究所,上海200001
  • 折叠

摘要

Abstract

Drug -induced liver injury (DILI) is one of the most important drug -induced diseases and has complex clinical phenotypes ,which leads to its unpredictability.The involvement of many types of drugs and complex population heterogeneity pose great challenges to the supervision of scientific research on DILI.Most of our knowledge of DILI comes from the international databases of long -term follow -up.However, there are still many unmet clinical needs in the field of DILI .Strengthening the scientific research on drug -induced liver injury based on big data helps us to understand DILI better and it is the premise for scientific supervision .

关键词

药物性肝损伤/数据库

Key words

drug -induced liver injury/database

分类

医药卫生

引用本文复制引用

茅益民..加强基于大数据的药物性肝损伤的科学研究和监管[J].临床肝胆病杂志,2018,34(6):1166-1168,3.

基金项目

"十三五"科技重大专项(2017ZX09304016) (2017ZX09304016)

国家自然科学基金课题(81670524) (81670524)

临床肝胆病杂志

OA北大核心CSTPCD

1001-5256

访问量0
|
下载量0
段落导航相关论文